Dogecoin Holders Looking For The Next 50x Gains In Q4 Back Viral Altcoin Remittix

Dogecoin Holders Looking For The Next 50x Gains In Q4 Back Viral Altcoin Remittix

The post Dogecoin Holders Looking For The Next 50x Gains In Q4 Back Viral Altcoin Remittix appeared on BitcoinEthereumNews.com.

Crypto News Dogecoin is heating up again, and early movers are watching one more name alongside it, referred to as Remittix (RTX). With Dogecoin trading near $0.20 and building higher lows, momentum traders see room for a fresh push if the chart clears key levels. At the same time, Remittix’s PayFi rails and growing on-chain traction are pulling in holders who want utility plus upside. Here is how both could fit a Q4 game plan. Dogecoin Price Setup For Q4 Dogecoin price is currently near $0.20. The Dogecoin chart indicates that the buyers are holding on to the $0.20 region and pushing the upward trend line at $0.1980. In case Dogecoin recovers $0.2120 and subsequently, $0.2180, technicians will target the next level of $0.2320 and potentially, $0.250. It would serve to elevate Dogecoin over the 100-hour moving average and reinforce the strength in the week. Due to the fact that Dogecoin is below $0.20, the trend line of $0.1980 would be a major support. A break beneath $0.1880 opens $0.1720. So far, the foundation seems to be positive: Dogecoin has already been restored between $0.1787 and $0.2182, which means that the buyers still intervene in the most depressing moments. As investors pursue a 50x story, Dogecoin will remain on the shortlist, but it is important to ensure that the price has crossed resistance. Why Remittix Is Winning Q4 Attention Remittix is a PayFi network that lets users send crypto and settle as bank transfers with flat fees and no hidden FX. The project’s traction is now hard to ignore: Remittix is priced at $0.1166, has sold over 678 million tokens, and has raised $27.4 million. Security and usability also stand out, with a #1 on CertiK badge for top-tier audit confidence and a wallet beta live for real-time testing. Remittix…